Open AccessThe Kahlbaum Syndrome is a Risk Factor for the Development of Neuroleptic Malignant Syndrome
Author(s) -
Lee
Publication year - 2011
Publication title -
journal of neurology research
Language(s) - English
Resource type - Journals
eISSN - 1923-2853
pISSN - 1923-2845
DOI - 10.4021/jnr36e
Subject(s) - catatonia , lorazepam , medicine , electroconvulsive therapy , neuroleptic malignant syndrome , olanzapine , diazepam , schizophrenia (object oriented programming) , risperidone , anesthesia , psychiatry , pediatrics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom